Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients

BACKGROUND: There is an insufficient number of reliable prognostic and response predictive biomarkers in colorectal cancer (CRC) management. In a previous study, we found that high tumour tissue expression of tumour-associated trypsin inhibitor (TATI) correlated with liver metastasis and an impaired...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaber, Alexander, Nodin, Björn, Hotakainen, Kristina, Nilsson, Elise, Stenman, Ulf-Håkan, Bjartell, Anders, Birgisson, Helgi, Jirström, Karin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946315/
https://www.ncbi.nlm.nih.gov/pubmed/20849596
http://dx.doi.org/10.1186/1471-2407-10-498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946315/
https://www.ncbi.nlm.nih.gov/pubmed/20849596
http://dx.doi.org/10.1186/1471-2407-10-498

Ejemplares similares